Market Closed -
OTC Markets
01:18:19 04/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.7266
USD
|
+0.87%
|
|
+8.95%
|
+57.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
133
|
792.6
|
593.8
|
148.9
|
90.46
|
142.9
|
-
|
-
|
Enterprise Value (EV)
1 |
133
|
788.3
|
626.1
|
312
|
338.7
|
330.6
|
358.7
|
142.9
|
P/E ratio
|
-
|
-2.78
x
|
24.9
x
|
-0.72
x
|
-1.39
x
|
-3.27
x
|
-3.63
x
|
-4.04
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
13
x
|
9.81
x
|
2.84
x
|
0.52
x
|
0.34
x
|
0.52
x
|
0.48
x
|
0.45
x
|
EV / Revenue
|
13
x
|
9.76
x
|
2.99
x
|
1.1
x
|
1.26
x
|
1.19
x
|
1.21
x
|
0.45
x
|
EV / EBITDA
|
-4.9
x
|
-301
x
|
36.9
x
|
44.1
x
|
8.31
x
|
6.56
x
|
5.75
x
|
2.52
x
|
EV / FCF
|
-
|
-31
x
|
-8.61
x
|
-3.98
x
|
-24.1
x
|
16.1
x
|
8.73
x
|
-
|
FCF Yield
|
-
|
-3.23%
|
-11.6%
|
-25.1%
|
-4.15%
|
6.23%
|
11.5%
|
-
|
Price to Book
|
-
|
326
x
|
-
|
-
|
-11.9
x
|
-4.27
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
96,358
|
1,35,257
|
1,82,707
|
1,95,449
|
1,96,630
|
1,96,633
|
-
|
-
|
Reference price
2 |
1.380
|
5.860
|
3.250
|
0.7620
|
0.4600
|
0.7266
|
0.7266
|
0.7266
|
Announcement Date
|
07/05/20
|
07/06/21
|
24/03/22
|
31/03/23
|
13/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10.23
|
80.77
|
209.3
|
284.3
|
269.4
|
277
|
297.4
|
314.8
|
EBITDA
1 |
-27.12
|
-2.616
|
16.94
|
7.073
|
40.77
|
50.38
|
62.37
|
56.7
|
EBIT
1 |
-34.15
|
-9.232
|
-22.56
|
-220.3
|
-2.818
|
13.45
|
-
|
-
|
Operating Margin
|
-333.89%
|
-11.43%
|
-10.78%
|
-77.5%
|
-1.05%
|
4.85%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-26.26
|
-201.5
|
56.4
|
-193.9
|
-33.3
|
-20.01
|
-
|
-
|
Net income
1 |
-30.61
|
-210
|
25.74
|
-202.3
|
-65.1
|
-49.91
|
-
|
-
|
Net margin
|
-299.24%
|
-259.94%
|
12.3%
|
-71.17%
|
-24.16%
|
-18.02%
|
-
|
-
|
EPS
2 |
-
|
-2.110
|
0.1304
|
-1.060
|
-0.3300
|
-0.2225
|
-0.2000
|
-0.1800
|
Free Cash Flow
1 |
-
|
-25.43
|
-72.74
|
-78.3
|
-14.06
|
20.6
|
41.1
|
-
|
FCF margin
|
-
|
-31.48%
|
-34.76%
|
-27.54%
|
-5.22%
|
7.44%
|
13.82%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
40.89%
|
65.9%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
07/05/20
|
07/06/21
|
24/03/22
|
31/03/23
|
13/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
53.98
|
65.89
|
61.89
|
72.76
|
72.82
|
76.82
|
69.87
|
66.42
|
65.38
|
67.77
|
65.69
|
68.09
|
69.91
|
72.81
|
EBITDA
1 |
6.354
|
1.484
|
1.065
|
0.522
|
0.653
|
6.03
|
7.603
|
12.62
|
9.71
|
11.34
|
10.43
|
12.27
|
13.05
|
19.22
|
EBIT
1 |
-0.153
|
-17.46
|
-9.119
|
-12.08
|
-12.85
|
-139.2
|
-2.511
|
3.4
|
2.826
|
-6.533
|
1.128
|
3.466
|
4.736
|
5.297
|
Operating Margin
|
-0.28%
|
-26.5%
|
-14.73%
|
-16.6%
|
-17.64%
|
-181.21%
|
-3.59%
|
5.12%
|
4.32%
|
-9.64%
|
1.72%
|
5.09%
|
6.77%
|
7.27%
|
Earnings before Tax (EBT)
1 |
47.14
|
18.77
|
-5.9
|
19.78
|
-57.5
|
-141.4
|
-2.292
|
-5.49
|
-12.61
|
-12.9
|
-7.938
|
-5.6
|
-4.331
|
-3.437
|
Net income
1 |
38.3
|
9.12
|
-14.31
|
12.07
|
-54.7
|
-139.9
|
-12.44
|
-14.04
|
-20.62
|
-18
|
-14.06
|
-12.8
|
-11.65
|
-11.22
|
Net margin
|
70.94%
|
13.84%
|
-23.12%
|
16.58%
|
-75.11%
|
-182.16%
|
-17.8%
|
-21.13%
|
-31.54%
|
-26.57%
|
-21.4%
|
-18.8%
|
-16.67%
|
-15.42%
|
EPS
2 |
0.2200
|
0.0432
|
-0.0800
|
0.0600
|
-0.2800
|
-0.7100
|
-0.0600
|
-0.0700
|
-0.1100
|
-0.0900
|
-0.0650
|
-0.0600
|
-0.0550
|
-0.0500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/11/21
|
24/03/22
|
25/05/22
|
29/08/22
|
22/11/22
|
31/03/23
|
12/05/23
|
11/08/23
|
14/11/23
|
13/03/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
32.3
|
163
|
248
|
188
|
216
|
-
|
Net Cash position
1 |
-
|
4.31
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.904
x
|
23.05
x
|
6.089
x
|
3.727
x
|
3.46
x
|
-
|
Free Cash Flow
1 |
-
|
-25.4
|
-72.7
|
-78.3
|
-14.1
|
20.6
|
41.1
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-334%
|
-22.7%
|
-84.1%
|
-328%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-73.8%
|
-4.12%
|
-16.3%
|
-12.6%
|
-18.4%
|
-
|
-
|
Assets
1 |
-
|
284.7
|
-624.1
|
1,238
|
515.5
|
271.3
|
-
|
-
|
Book Value Per Share
2 |
-
|
0.0200
|
-
|
-
|
-0.0400
|
-0.1700
|
-
|
-
|
Cash Flow per Share
2 |
-
|
-
|
0.0100
|
-0.1000
|
-0.0200
|
-0.0100
|
0.1300
|
-
|
Capex
1 |
58.7
|
21.7
|
74.3
|
56.9
|
10.7
|
5
|
-
|
-
|
Capex / Sales
|
573.96%
|
26.87%
|
35.51%
|
20.01%
|
3.99%
|
1.81%
|
-
|
-
|
Announcement Date
|
07/05/20
|
07/06/21
|
24/03/22
|
31/03/23
|
13/03/24
|
-
|
-
|
-
|
Last Close Price
0.7266
USD Average target price
1.083
USD Spread / Average Target +49.11% Consensus |
1st Jan change
|
Capi.
|
---|
| +57.96% | 143M | | +47.74% | 289M | | +30.93% | 270M | | +48.84% | 193M | | -14.29% | 145M | | +147.89% | 141M | | -7.69% | 80.17M | | +150.00% | 75.33M | | +43.75% | 66.15M | | +12.07% | 58.3M |
Medical Farming
|